SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-231237
Filing Date
2017-07-19
Accepted
2017-07-19 16:00:32
Documents
3
Period of Report
2017-07-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d423592d8k.htm 8-K 18923
2 EX-99.1 d423592dex991.htm EX-99.1 245322
3 GRAPHIC g423592g0713135531344.jpg GRAPHIC 22444
  Complete submission text file 0001193125-17-231237.txt   296444
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 17972341
SIC: 2834 Pharmaceutical Preparations